Nucleolar organizer regions in differentiated preneoplastic and neoplastic endometrial lesions

Gynecologic and Obstetric Investigation

Volumn 47, Issue 3, 1999, Pages 205-209

  Terlikowski, Stawomir ^a   Lenczewski, Andrzej ^b   Sulkowski, Stanisław ^b   Kulikowski, Marek ^b  

^a MEDICAL UNIVERSITY OF BIALYSTOK   (Poland)

^b NONE

Author keywords

Cell proliferation; Endometrial adenocarcinoma; Endometrial hyperplasia; Nucleolar organizer regions

Indexed keywords

PARAFFIN; SILVER NITRATE;

ARTICLE; CELL PROLIFERATION; CHROMOSOME NOR; ENDOMETRIUM CARCINOMA; ENDOMETRIUM HYPERPLASIA; FEMALE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; PATHOLOGY; PRIORITY JOURNAL; RETROSPECTIVE STUDY;

EID: 0033008954     PISSN: 03787346     EISSN: None     Source Type: Journal    
DOI: 10.1159/000010096     Document Type: Article

References (32)

1. Kurman RJ, Norris HJ: Endometrial hyperplasia and related cellular changes; in Kurman RJ (ed): Blaustein's Pathology of the Female Genital Tract. New York, Springer, 1994, pp 411-437.
2. Sivridis EL: Histological evaluation of the endometrium: From hyperplasia to cancer. Eur J Gynaecol Oncol 1996;5:440-442.
3. Kurman RJ, Kaminski PF, Norris HJ: The behaviour of endometrial hyperplasia. A long-term study of 'untreated' hyperplasia in 170 patients. Cancer 1985;56:403-412.
4. Lurain JR, Rice BL, Rademaker AW, Poggensee LE, Schink JC, Miller DS: Prognostic factors associated with recurrence in clinical stage I adenocarcinoma of the endometrium. Obstet Gynecol 1991;78:63-69.
5. Schink JC, Rademaker AW, Miller DS, Lurain JR: Tumor size in endometrial cancer. Cancer 1991;67:2791-2794.
6. Kurman RJ, Zaino RJ, Norris HJ: Endometrial carcinoma; in Kurman RJ (ed): Blaustein's Pathology of the Female Genital Tract. New York, Springer, 1994, pp 439-486.
7. Ambros RA, Kurman RJ: Combined assessment of vascular and myometrial invasions as a model to predict prognosis in stage I endometrial adenocarcinoma of the uterine corpus. Cancer 1992;69:1424-1431.
8. Moberger B, Auer G, Einhorn N, Mobergcr G: The prognostic significance of growth pattern and its relation to tumor cell nuclear DNA content in endometrial carcinoma. Acta Oncol 1990;29:17-23.
9. Rose PG: Endometrial cancer. N Engl J Med 1996;335:640-649.
10. Ploton D, Menager M, Jeannesson P, Himber G, Pigeon F, Adnett JJ: Improvement in the staining and in the visualization of the argyrophilic proteins of the nucleolar organizer region at the optical level. Histochem J 1986;18:5-14.
11. Howell WM: Selective staining of nucleolus organizer regions (NORs); in Bush H, Rothblum L (eds): The Cell Nucleus, vol II. New York, Academic Press, 1992, pp 89-142.
12. Crocker J, Nar P: Nucleolar organizer regions in lymphomas. J Pathol 1987;151:111-118.
13. Derenzini M, Ploton D: Interphase nucleolar organizer regions in cancer cells. Int Rev Exp Pathol 1991;32:150-192.
14. Egan NJ, Crocker J: Nucleolar organizer regions in pathology. Br J Cancer 1992;65:1-7.
15. Terlikowski S, Sulkowski S, Sulkowska M, Lenezewski A, Łotocki W: Differential expression of AgNORs in selected states of endometrial proliferation. Gin Pol 1996;67(suppl 6): 141-145.
16. Trabucco S, Varcaccio-Garofalo G, Botticella MA, De-Stefano R, Capursi T, Resta L: Expression of AgNORs in serous ovarian tumors. Eur J Gynaecol Oncol 1994;3:222-229.
17. Aaltomaa S, Lipponen P, Syrjanen K: Nucleolar organizer regions related to morphometry, flow cytometry, sex steroid receptor content, tumour histology and prognosis in female breast cancer. Pathol Res Pract 1993;4:416-421.
18. Ohri AK, Ohri SK, Herbert A, Royle G, Taylor I: The relationship between clinical staging, oestrogen receptor status and silver-binding nucleolar organiser regions (AgNOR) in breast carcinoma. Eur J Surg Oncol 1992;2:103-107.
19. Aubele M, Auer G, Jutting U, Falkmer U. Gais P: Prognostic value of quantitatively measured AgNORs in ductal mammary carcinoma. Anal Quant Cytol Histol 1994;3:211-218.
20. Criscuolo M, Martinelli AM, Migaldi M, Zunarelli E, Bergamaschi M, Falchi AM, De Gaetani C: Prognostic significance of nucleolar organizer regions in ovarian epithelial tumors. Int J Gynecol Pathol 1993;3:259-263.
21. Brustmann H, Riss P. Naude S: Nucleolar organizer regions as markers of endometrial proliferation: A study of normal, hyperplastic, and neoplastic tissue. Hum Pathol 1995;26: 664-667.
22. Coumbe A, Mills BP, Brown CL: Nucleolar organizer regions in endometrial hyperplasia and neoplasia. Pathol Res Pract 1990;186:254-259.
23. Miller B, Morris M, Silva E: Nucleolar organizer regions: A potential prognostic factor in adenocarcinoma of the endometrium. Gynecol Oncol 1994;54:137-141.
24. Niwa K, Yokoyama Y, Tanaka T, Mori H, Mori H, Tamaya T: Silver-stained nucleolar organizer regions in the normal, hyperplastic and neoplastic endometrium. Virchows Arch A Pathol Anat Histopathol 1991;419:493-497.
25. Papadimitiou C, Athanasiadou S, Stylianidou A, Karameris A: Nucleolar organizer regions in normal, hyperplastic, and carcinomatous epithelium of endometrium. Virchows Arch B Cell Pathol 1991;60:155-160.
26. Trere D, Melchiorri C, Chieco P, Marabini A, Derenzini M: Interphase AgNOR quantity and DNA content in endometrial adenocarcinoma. Gynecol Oncol 1994;53:202-207.
27. Wilkinson N, Buckley CH, Chawner L, Fox H: Nucleolar organizer regions in normal, hyperplastic, and neoplastic endometrium. Int J Gynecol Pathol 1990;9:55-59.
28. Simon R, Altman DG: Statistical aspects of prognostic factor studies in oncology. Br J Cancer 1994;69:979-985.
29. Morton CC, Brown JA, Holmes WM, Nance WE, Wolf B: Stain intensity of human nucleolus organizer region reflects incorporation of uridine into mature ribosomal RNA. Exp Cell Res 1983;145:405-413.
30. Hall PA, Levison DA: Review: Assessment of cell proliferation in histological materials. J Clin Pathol 1990;43:184-192.
31. Gallup DG, Stock RJ: Adenocarcinoma of the endometrium in women 40 years of age or younger. Obstet Gynccol 1984;64:417-419.
32. Clement PB: Pathology of the uterine corpus. Hum Pathol 1991;22:776-791.